Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
UBS
Argus Health
Farmers Insurance
Dow
Federal Trade Commission
Express Scripts
Colorcon
Healthtrust
Daiichi Sankyo

Generated: August 19, 2017

DrugPatentWatch Database Preview

RILUTEK Drug Profile

« Back to Dashboard

Which patents cover Rilutek, and when can generic versions of Rilutek launch?

Rilutek is a drug marketed by Covis Pharma Sarl and is included in one NDA.

The generic ingredient in RILUTEK is riluzole. There are nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the riluzole profile page.

Summary for Tradename: RILUTEK

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list5
Bulk Api Vendors: see list101
Clinical Trials: see list8
Patent Applications: see list3,266
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:RILUTEK at DailyMed

Pharmacology for Tradename: RILUTEK

Ingredient-typeBenzothiazoles
Drug ClassBenzothiazole
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Covis Pharma Sarl
RILUTEK
riluzole
TABLET;ORAL020599-001Dec 12, 1995ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: RILUTEK

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Covis Pharma Sarl
RILUTEK
riluzole
TABLET;ORAL020599-001Dec 12, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Healthtrust
Daiichi Sankyo
Chinese Patent Office
Merck
Chubb
UBS
Fuji
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot